In the present study, 11 patients showing tumor recurrence had median pretransplant levels of AFP 4.4 ng/mL and PIVKA-II 23 mAU/mL, which were not different from those in the other 155 patients without tumor recurrence. Here, AFP is linked to neoplasm.